Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine
The purpose of this article is to provide a focused overview of the current use of positron emission tomography (PET) molecular imaging in the burgeoning era of personalized medicine in the treatment of patients with glioma. Specifically, we demonstrate the utility of PET imaging as a tool for perso...
Main Authors: | Ramon F. Barajas, Kenneth A. Krohn, Jeanne M. Link, Randall A. Hawkins, Jennifer L. Clarke, Miguel H. Pampaloni, Soonmee Cha |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-9059/4/4/24 |
Similar Items
-
FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer
by: Martin Dolezel, et al.
Published: (2022-07-01) -
First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer
by: Sébastien Thureau, et al.
Published: (2021-08-01) -
Comparison of FDG and FMISO uptakes and distributions in head and neck squamous cell cancer tumors
by: Sadek A. Nehmeh, et al.
Published: (2021-04-01) -
Increased [18F]FMISO accumulation under hypoxia by multidrug-resistant protein 1 inhibitors
by: Yoichi Shimizu, et al.
Published: (2021-01-01) -
Evaluation of 18F-FMISO PET and 18F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy
by: Sze Ting Lee, et al.
Published: (2021-03-01)